A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine

NCT03369808 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

H7N9 Influenza

Interventions

BIOLOGICAL: 7.5μg H7N9 Vaccine
BIOLOGICAL: Phosphate Buffer Solution
BIOLOGICAL: Aluminum Hydroxide Adjuvant
BIOLOGICAL: 15μg H7N9 Vaccine
BIOLOGICAL: 30μg H7N9 Vaccine

Sponsor

Shanghai Institute Of Biological Products

Collaborators

[object Object]